Dublin, Jan. 02, 2020 (GLOBE NEWSWIRE) -- The "Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global point-of-care diagnostics market is projected to reach USD 46.7 billion by 2024 from USD 28.5 billion in 2019, at a CAGR of 10.4%.
Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target conditions, and increasing inclination toward home healthcare across the globe are driving the market for point-of-care diagnostics. However, product recalls, a lack of alignment with test results obtained from laboratories, stringent & time-consuming approval policies, and a reluctance to change existing diagnostic practices are expected to restrain market growth.
The glucose monitoring products segment is expected to command the largest share of the POC diagnostics market in 2019.
Based on product, the point-of-care diagnostics market is segmented into glucose monitoring, infectious disease testing, cardiometabolic monitoring, coagulation monitoring, hematology testing, urinalysis testing, cholesterol testing, drugs-of-abuse testing, tumor/cancer markers, pregnancy & fertility testing, fecal occult testing, and other POC products. The glucose monitoring products segment is expected to command the largest share of the market in 2019. The increasing number of POC glucose monitoring devices, coupled with the growing prevalence of diabetes, is expected to drive the growth of the POC diagnostics market for glucose monitoring products in the coming years.
The microfluidics segment is expected to register the highest growth rate in the POC diagnostics market, by platform, during the forecast period.
On the basis of platform, the point-of-care diagnostics market is segmented into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. The microfluidics segment is expected to register the highest growth rate during the forecast period. Technological advancements and increasing initiatives by market players for developing novel microfluidics-based POC products are propelling the growth of the microfluidics market.
The Asia Pacific market is expected to register the highest CAGR during the forecast period.
The point-of-care diagnostics market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to register the highest growth rate during the forecast period, due to the growing initiatives by market players, increasing patient population base, and rising number of partnerships and joint ventures in this region.
This report studies the point-of-care diagnostics market based on product, platform, mode of purchase, end user, and region. The report also studies factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends. The report forecasts the revenue of the market segments with respect to the five key regions and their respective countries.
Key Topics Covered:
Premium Insights
- POC Diagnostics Market Overview
- Geographic Analysis: POC Diagnostics Market
- POC Diagnostics Market, By Product
- POC Diagnostics Market, By Prescription Mode
- Geographic Snapshot of the POC Diagnostics Market
Market Overview
Point-Of-Care Diagnostics Market, By Product
- Glucose Monitoring Products
- Cardiometabolic Monitoring Products
- Infectious Disease Testing Products
- Coagulation Monitoring Products
- Pregnancy & Fertility Testing Products
- Tumor/Cancer Marker Testing Product
- Urinalysis Testing Products
- Cholesterol Testing Products
- Drugs-Of-Abuse Testing Products
- Fecal Occult Testing Products
- Other POC Products
Point-Of-Care Diagnostics Market, By Platform
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular Diagnostics
- Immunoassays
Point-Of-Care Diagnostics Market, By Mode of Purchase
- Prescription-Based Products
- Growing Prevalence of Lifestyle Diseases and Favorable Reimbursement Have Driven Market Growth
- OTC Products
- Rising Focus on Home Care is Expected to Boost Demand for OTC Testing in the Coming Years
Point-Of-Care Diagnostics Market, By End User
- Professional Diagnostic Centers
- Hospitals/Critical Care Centers
- Home Care Settings
- Research Laboratories
- Other End Users
Point-Of-Care Diagnostics Market, By Region
Competitive Landscape
- Ranking of Players, 2018
- Competitive Scenario
- Product Launches, Enhancements, and Approvals
- Agreements, Partnerships, and Collaborations
- Acquisitions
- Vendor Dive Overview
- Vendor Inclusion Criteria
- Vendor Dive
Company Profiles
- Abbott Laboratories
- Becton, Dickinson, and Company
- Chembio Diagnostics
- Danaher Corporation
- Johnson & Johnson
- Roche Diagnostics
- Siemens Healthineers Group
- EKF Diagnostics
- Quidel
- Trinity Biotech
- Accubiotech
- Instrumentation Laboratory
- Nova Biomedical
- PTS Diagnostics
- Sekisui Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/11cnl3
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.